Literature DB >> 8228376

Cytomegalovirus resistant to foscarnet: clinicovirologic correlation in a patient with human immunodeficiency virus.

C Leport, S Puget, J M Pepin, S Levy, C Perronne, F Brun-Vezinet, J L Vildé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8228376     DOI： 10.1093/infdis/168.5.1329

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.

Authors:  M L Landry; S Stanat; K Biron; D Brambilla; W Britt; J Jokela; S Chou; W L Drew; A Erice; B Gilliam; N Lurain; J Manischewitz; R Miner; M Nokta; P Reichelderfer; S Spector; A Weinberg; B Yen-Lieberman; C Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples.

Authors:  G Gerna; A Sarasini; E Percivalle; M Zavattoni; F Baldanti; M G Revello
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

3.  Nucleotide analogs related to acyclovir and ganciclovir are effective against murine cytomegalovirus infections in BALB/c and severe combined immunodeficient mice.

Authors:  D F Smee; S T Sugiyama; E J Reist
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

4.  Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.

Authors:  D A Jabs; C Enger; M Forman; J P Dunn
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

5.  Potent anti-murine cytomegalovirus activity and reduced nephrotoxicity of ganciclovir cyclic phosphonate.

Authors:  D F Smee; E J Reist
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 6.  Ganciclovir. An update of its therapeutic use in cytomegalovirus infection.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

Review 7.  What clinicians need to know about antiviral drugs and viral resistance.

Authors:  R L Hodinka
Journal:  Infect Dis Clin North Am       Date:  1997-12       Impact factor: 5.982
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.